IL2RA MAb - CSB0026

Catalog #: CSB0026
Application: FC, IF
Isotype: Mouse IgG2a
Reactivity: Human (other untested)
Concentration: 1 mg/ml
Size: 100 µg
Technical Data Sheet
Safety Data Sheet
$475.00
Adding to cart… The item has been added
  • Description
Description

CSB VeRSaMAbs:
We produce and validate all our monoclonal antibodies in-house so that you can confidently choose the right antibody for your assay. All antibodies are VALIDATED for common applications, RECOMBINANT for batch-to-batch consistency, and SPECIFIC in binding to only your target.

TargetIL2RA
Target AliasesCD25, IDDM10, IL2R, P55, IMD41, TCGFR
IsotypeMouse IgG2a
Membrane Proteome SpecificityMonospecific for 6,000 membrane proteins tested
Species ReactivityHuman (other untested)
Fc ModificationsC-terminal Avitag, disabled Fc-gamma receptor binding
SourceRecombinant CHO expression; purified by Protein A chromatography
FormulationEndotoxin Free PBS pH 7.4, sterile-filtered
Concentration1 mg/ml
Specificity ProfileMore Information

The specificity of IL2RA Monoclonal Antibody (CSB0026) was tested on the Membrane Proteome Array and shown to be specific for human IL2RA.

The Membrane Proteome Array contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Array represents the industry standard for determining the binding specificity of antibodies and other protein ligands.

ApplicationConditionsRecommended Concentration
Flow Cytometry, ExtracellularLive, Unpermeabilized1 µg/mL
HEK-293F cells transiently transfected with human IL2RA were stained with IL2RA Monoclonal Antibody (CSB0026) (green) or isotype control antibody (gray), followed by AlexaFluor 647-conjugated anti-mouse IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with IL2RA Monoclonal Antibody (CSB0026) (blue).
ApplicationConditionsRecommended Concentration
Immunofluorescence, ExtracellularFixed 4% paraformaldehyde1 µg/mL
(A) COS-7 cells transiently transfected with human IL2RA were stained with IL2RA Monoclonal Antibody (CSB0026) followed by AlexaFluor 647 anti-mouse IgG secondary antibody (red) and DAPI (blue). (B) COS-7 cells transiently transfected with an empty control vector stained with IL2RA Monoclonal Antibody. (C) Isotype control: COS-7 cells transfected with human IL2RA and stained with control MAb.
ApplicationConditionsRecommended Concentration
Immunofluorescence, IntracellularFixed 4% paraformaldehyde, Permeabilized 0.1% triton1 µg/mL
(A) COS-7 cells transiently transfected with human IL2RA were permeabilized and stained with IL2RA Monoclonal Antibody (CSB0026) followed by AlexaFluor 647 anti-mouse IgG secondary antibody (red) and DAPI (blue). (B) COS-7 cells transiently transfected with an empty control vector stained with IL2RA Monoclonal Antibody. (C) Isotype control: COS-7 cells transfected with human IL2RA and stained with control MAb.

Stable for 12 months from date of receipt when stored at 4°C. Avoid repeated freeze-thaw cycles.

IL2-Ra is a single-pass transmembrane protein and the alpha chain of the high-affinity IL2 receptor, which also includes beta and gamma chains. CD25 is involved in the regulation of immune tolerance. Severe COVID-19 causes elevated levels of IL2R in plasma, and elevated IL2R in serum is associated with some types of carcinomas. (NCBI Gene: 3559, UniProtKB/Swiss-Prot: P01589). This antibody uses the same variable regions as the clinical Daclizumab antibody. Daclizumab is indicated to treat relapsing-remitting forms of multiple sclerosis (https://medlineplus.gov/druginfo/meds/a616036.html). Other names: CD25, IDDM10, IL2R, P55, IMD41, TCGFR

Circle Icon